KR20150063183A - Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity - Google Patents

Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity Download PDF

Info

Publication number
KR20150063183A
KR20150063183A KR1020130146830A KR20130146830A KR20150063183A KR 20150063183 A KR20150063183 A KR 20150063183A KR 1020130146830 A KR1020130146830 A KR 1020130146830A KR 20130146830 A KR20130146830 A KR 20130146830A KR 20150063183 A KR20150063183 A KR 20150063183A
Authority
KR
South Korea
Prior art keywords
licorice
extract
fermentation extract
dermis
fermented
Prior art date
Application number
KR1020130146830A
Other languages
Korean (ko)
Other versions
KR102120220B1 (en
Inventor
심진섭
이지해
이지혜
김지연
심종원
염명훈
조준철
이찬우
최호민
성수현
Original Assignee
(주)아모레퍼시픽
주식회사 두래
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽, 주식회사 두래 filed Critical (주)아모레퍼시픽
Priority to KR1020130146830A priority Critical patent/KR102120220B1/en
Publication of KR20150063183A publication Critical patent/KR20150063183A/en
Application granted granted Critical
Publication of KR102120220B1 publication Critical patent/KR102120220B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332Promoters of weight control and weight loss

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a natural plant fermented extract exhibiting an abdominal slimming effect and, more specifically, to a composition for reinforcing an abdominal slimming effect, wherein licorice and dried orange peel fermented extracts are included to control the decomposition and differentiation of fat cells.

Description

천연식물 발효 추출물을 함유하는 복부 비만 감소용 화장료 또는 식품 조성물{Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity} [0001] The present invention relates to a cosmetic or food composition for reducing abdominal obesity containing a natural plant fermentation extract,

본 발명은 복부 슬리밍 효능을 나타내는 천연식물 발효 추출물에 관한 것으로, 더욱 상세하게는, 감초 및 진피 발효 추출물을 함유함으로써 지방 세포 내 지방을 분해 하고 지방 세포의 분화를 억제함으로써 복부의 슬리밍 효능을 강화시키는 조성물에 관한 것이다.The present invention relates to a natural plant fermentation extract showing abdominal slimming efficacy, and more particularly, it relates to a plant fermentation extract which exhibits an abdominal slimming effect, and more particularly, ≪ / RTI >

복부 비만은 잘못된 식생활과 무절제한 생활, 과도한 스트레스, 운동 결핍 등으로 기초대사량이 저하되어 있는 경우 쉽게 나타난다. 임상적으로 비만 정도는 허리와 엉덩이의 비율(Waist/Hip ratio)로 측정되며, 남성의 경우 W/H 비가 0.9 이상일 때는 복부 비만으로 분류하고, 여성의 경우는 0.85 이상일 때는 복부 비만으로 분류가 된다. 남성의 경우는 기본적으로 여자에 비하여 내장지방이 2~3배 많으며, 대개 음주와 흡연 및 고지방 음식을 섭취하는 경우가 많아 복부 비만이 생기기 쉽다. 여성의 경우는 폐경기 이후에 난소폐쇄(follicular atresia)로 인한 에스트로겐 합성과 분비의 감소 및 뇌하수체로부터 분비되는 성선 자극 호르몬 수치의 상승으로 인하여 나타나는 다양한 질병 중 하나로, 복부지방 조직이 증가하게 된다(Choi Y,Yoon et al. Korean J.Nutr.34(3):322-329,2001 및 Turcato E.et al.J Intern Med 241(5):363-372,1997). Abdominal obesity is easily manifested when there is a decrease in basal metabolism due to erroneous dietary life, uneventful life, excessive stress, and lack of exercise. Clinically, the degree of obesity is measured by the ratio of waist to hip ratio. In males, the W / H ratio is classified as abdominal obesity when the ratio is 0.9 or more, and when it is 0.85 or more, it is classified as abdominal obesity . In males, visceral fat is 2 ~ 3 times more than females basically, and abdominal obesity is likely to occur because they are often consumed by drinking and smoking and high fat foods. In women, postmenopausal follicular atresia results in decreased estrogen synthesis and secretion, and increased gonadal hormone secretion from the pituitary gland, leading to increased abdominal fat tissue (Choi Y , Yoon et al. Korean J. Nutr. 34 (3): 322-329, 2001 and Turcato E. et al. J Intern Med 241 (5): 363-372, 1997).

비만을 치료하고 예방하는 방법은 여러 나라에서 활발하게 다각적인 측면에서 연구되고 있으나, 비만개선 및 예방을 위해서는 식품의 섭취를 줄이고 에너지 소비를 늘림으로써 지방의 체내축적을 억제하는 것이 중요하다. 특히 에너지 소비를 증가시키기 위해 운동이 가장 효과적인 것으로 알려져 있으나, 교통통신의 발달로 인해 점점 운동량이 감소되고 현대 생활에 있어 매일 규칙적으로 운동을 하기는 어려운 측면이 많다. 또한 식이조절을 통한 비만개선도 식사량을 줄이는 일 자체가 어렵고 잦은 외식과 고열량 인스턴트 식품의 범람으로 인해 용이하지 않은 형편이다. 또 다른 치료방법으로 약물요법과 수술요법이 있지만 두 방법 모두 안전과 경제적 측면에서 시행하기에 어려운 점이 많다. 따라서, 안전성 및 수행하기에 상대적으로 용이한 점으로 인해 슬리밍 외용제 및 슬리밍 식품에 대한 관심도가 지속적으로 증가하는 상황이다.It is important to prevent the accumulation of fat in the body by reducing food intake and increasing energy consumption, although obesity is being actively and diverse in many countries. Particularly, it is known that exercise is the most effective way to increase energy consumption. However, due to the development of traffic communication, the amount of exercise is gradually decreasing and it is difficult to exercise regularly every day in modern life. Also, improvement of obesity through dietary control is not easy to reduce the amount of food, and it is not easy due to frequent eating out and overfilling of high-calorie instant food. Other therapies include pharmacotherapy and surgery, but both are difficult to implement in terms of safety and economics. Therefore, interest in slimming products and slimming foods is continuously increasing due to safety and relative ease of carrying out.

대한민국공개특허공보 제2013-0099572호(공개일: 2013.09.06)Korean Laid-Open Patent Publication No. 2013-0099572 (Publication date: 2013.09.06)

본 발명자들은 천연식물 발효 추출물, 구체적으로 감초 및 진피를 발효 시킨 후 수득한 감초 발효 추출물 및 진피 발효 추출물의 혼합물은 지방 세포 내 지방 분해 및 지방 세포 분화 억제 효과가 우수함을 발견하고 본 발명을 완성하였다.The inventors of the present invention discovered that the mixture of fermented extract of natural plant, fermented licorice and dermis, and the mixture of fermented licorice fermented extract and fermented dermis extract were superior in fat lipid degradation and adipocyte differentiation inhibition in fat cells, and completed the present invention .

따라서, 본 발명의 목적은 지방 세포 내 지방 분해 및 지방 세포의 분화를 억제함으로써 복부 비만을 완화시키는 천연식물 발효 추출물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a natural plant fermentation extract which alleviates abdominal obesity by inhibiting lipolysis in adipocytes and differentiation of adipocytes.

상기한 목적을 달성하기 위하여, 본 발명은 감초 발효 추출물 및 진피 발효 추출물의 혼합물을 함유하는 화장료 조성물 또는 식품 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition or a food composition containing a mixture of licorice fermented extract and dermis fermented extract.

본 발명의 천연식물 발효 추출물을 이용하면, 지방 세포 내 지방 분해 및 지방 세포의 분화를 억제할 수 있다. 따라서, 상기 천연식물 발효 추출물을 복부 슬리밍을 위한 화장료 조성물 또는 식품 조성물의 유효 성분으로 사용할 수 있다The use of the natural plant fermentation extract of the present invention can inhibit lipolysis in adipocytes and differentiation of adipocytes. Accordingly, the natural plant fermentation extract can be used as an effective ingredient of a cosmetic composition or a food composition for abdominal slimming

본 발명은 복부 슬리밍 효능을 나타내는 천연식물 발효 추출물 및 이를 함유하는 화장료 또는 식품 조성물에 관한 것이다.The present invention relates to a natural plant fermentation extract showing abdominal slimming efficacy and a cosmetic composition or food composition containing the same.

이하, 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described more specifically.

본 발명의 “감초(Glycyrrhiza uralensis Fischer)”는 콩과의 다년생 풀로, 뿌리 및 뿌리줄기를 감초(甘草), 뿌리줄기 윗끝의 노두(蘆頭) 부분을 감초두(甘草頭), 뿌리 끝 부분 또는 잔뿌리를 감초초(甘草梢), 뿌리 혹은 뿌리줄기 속에 들어 있는 흑갈색의 수지처럼 생긴 물질의 일부인 감초절(甘草節)이라고 하며, 모두 본원에 포함된다. The " licorice ( Glycyrrhiza uralensis Fischer ) is a perennial plant of soybean with roots and rootstocks of licorice; the root of the rootstock is the licorice root; the end of root or the root of root is licorice root; , Licorice, which is a part of a material that appears like a dark brown resin contained in roots or rootstocks, and is included in this application.

본 발명의 “진피”라 함은 진귤(Citrus sunki Hort . ex Tanaka)로서 제주도에 분포하고 있는 쌍떡잎식물 쥐손이풀목 운향과에 속하는 귤나무이다. 열매의 향과 맛이 독특하여 지난날 세금으로 바치던 지방 특산물 중에서도 상품에 속했다. 제주도에서 감귤을 재배하기 시작한 것이 언제인지 단정할 수는 없으나, 감귤에 관한 문헌상의 기록으로 1052년(고려 문종 6)에 “세공귤자를 100포로 정한다”고 하였으니, 이미 11세기부터 제주도에서 감귤을 진상하고 있었다고 추정되고, 따라서 그 이전부터 감귤이 재배되었을 것이므로 제주 감귤의 재배 역사는 매우 오래되었다고 볼 수 있다. 전통적으로는 진귤(陳橘-제주감귤농협자료, 山橘-조선왕조실록, 산물-제주방언, 酸橘-중국, Sunki-일본어발음, Citrus sunki Hort. ex Tanaka)의 묵은 과피가 약용으로 사용되어 왔다. 조선시대 숙종조 탐라순력도(耽羅巡歷圖)의 감귤봉진(柑橘封進)에는 한약재로 따로 진상한 귤껍질이 적혀 있는데, “진피(陳皮)는 진귤의 껍질”로 기록되어 있다.The term "dermal" in this invention means the jingyul (Citrus proclamation Hort . ex Tanaka ) is a tangerine tree belonging to the mulberry tree, which is distributed in Jeju Island. The fragrance and flavor of the fruit is unique and belonged to the commodity among the local specialties that were offered as tax in the past. It can not be concluded when the citrus began to grow on Jeju Island, but it is said in the literature on citrus as 1052 (Goryeongjong 6) It is presumed that it has been developed and therefore the citrus has been cultivated before that, so the cultivation history of Jeju citrus can be regarded as very old. Traditionally, the old peels of citrus (Chen Tachibana - Jeju Citrus Nutrition Materials, Sanchung - Chosun Dynasty Annals, Products - Jeju dialect, Sanchung - China, Sunki - Japanese pronunciation, Citrus sunki Hort. Ex Tanaka) come. The mandarin bark of mandarin duck is described in the mandarin bark of mandarin duck in the Joseon Dynasty. The "mandarin bark" is recorded as "the bark of mandarin orange."

본 발명의 “감초 발효” 또는 “진피 발효”라 함은 상기 감초 또는 진피를 알파-아밀라아제(α-amylase), 베타-아밀라아제(β-amylase), 글루코-아밀라아제(gluco-amylase), 프로티아제(protease), 셀룰라아제(cellulase), 펙티나아제(pectinase), 알파-글루코시다아제(α-glucosidase), 베타-갈락토시다아제(β- galactosidase), 1,4-베타-D-글루카나아제(1,4-β-D-glucanase) 등의 효소 또는 이들의 혼합 효소로 발효하여 발효물을 얻는 것을 의미한다.The term " licorice fermentation " or " dermis fermentation " of the present invention means that the licorice or dermis is replaced with an alpha-amylase, a beta -amylase, a gluco-amylase, protease, cellulase, pectinase, alpha-glucosidase, beta-galactosidase, 1,4-beta-D-glucanase (1,4-β-D-glucanase) or a mixed enzyme thereof to obtain a fermented product.

상기 “감초 발효 추출물” 또는 “진피 발효 추출물”은 추출 대상인 감초 또는 진귤의 과피 발효 추출물을 메탄올, 에탄올 등의 탄소수 1 내지 4의 알코올, 70% 에탄올(주정), 아세톤, 에틸아세테이트, 클로로포름, 메틸렌클로라이드, 물, 또는 이들의 혼합 용매로 추출하여 얻어진 추출물과 그 추출물에서 상기 열거된 용매로 더 정제된 분획물을 포함하는 의미로서 이해된다. The "licorice fermentation extract" or "dermis fermentation extract" may be prepared by dissolving a percolated fermented extract of licorice or mandarin orange, which is a target to be extracted, with an alcohol having 1 to 4 carbon atoms such as methanol and ethanol, 70% ethanol (alcohol), acetone, ethyl acetate, Chloride, water, or a mixed solvent thereof, and fractions further purified with the above-listed solvents in the extracts.

본 발명은 상기 방법에 의해 제조된 감초 또는 진피의 발효 추출물로부터 추출한 감초 발효 추출물 또는 진피 발효 추출물을 각각 조성물 총 중량에 대하여 0.000001~30.0중량%의 양으로 함유할 수 있으며, 바람직하게는 감초 발효 추출물 또는 진피 발효 추출물을 각각 조성물 총 중량에 대하여 0.01~5.0중량%의 양으로 함유할 수 있다. 상기 감초 발효 추출물 또는 진피 발효 추출물이 0.000001중량% 미만의 양으로 함유되면 상기 성분에 의한 효과가 미약하고, 30.0중량% 초과의 양으로 함유되면 제형상의 문제점이 생길 수 있기 때문이다. In the present invention, the licorice fermentation extract or the dermis fermentation extract extracted from the fermentation extract of licorice or dermis produced by the above method may be contained in an amount of 0.000001 to 30.0 wt%, respectively, based on the total weight of the composition, Or dermis fermentation extract in an amount of 0.01 to 5.0% by weight based on the total weight of the composition. If the licorice fermentation extract or the dermis fermentation extract is contained in an amount of less than 0.000001 wt%, the effect of the ingredient is insufficient, and if it is contained in an amount of more than 30.0 wt%, problems may arise.

본 발명에 있어서, 감초 발효 추출물와 진피 발효 추출물은 중량비로 0.01~100:1의 범위로 혼합하여 사용된다. 또한, 상기 두 성분의 병용에 따른 상승 효과를 극대화하기 위하여, 바람직하게는 감초 발효 추출물와 진피 발효 추출물은 중량비로 0.1~10:1의 범위로 혼합하여 사용할 수 있다.In the present invention, the licorice fermentation extract and the dermis fermentation extract are mixed in a weight ratio of 0.01 to 100: 1. In order to maximize the synergistic effect of the combination of the two components, the licorice fermentation extract and the dermis fermentation extract may be mixed in a weight ratio of 0.1 to 10: 1.

본 발명의 조성물은 피부 외용제 조성물, 특히 화장료 조성물로서 제형화될 수 있으며, 화장품학 또는 피부과학적으로 허용 가능한 매질 또는 기제를 함유하여 제형화될 수 있다. 또한, 본 발명의 조성물은 국소 적용에 적합한 모든 제형으로 제공될 수 있으며, 예를 들어 용액, 수상에 유상을 분산시켜 얻은 에멀젼, 유상에 수상을 분산시켜 얻은 에멀젼, 현탁액, 고체, 겔, 분말, 페이스트, 포말(foam) 또는 에어로졸 조성물의 제형으로 제공될 수 있다. 이러한 제형의 조성물은 당해 분야의 통상적인 방법에 따라 제조될 수 있다.The composition of the present invention may be formulated as an external preparation for skin, in particular as a cosmetic composition, and may be formulated containing a cosmetically or dermatologically acceptable medium or base. In addition, the composition of the present invention may be provided in any form suitable for topical application, for example, as a solution, an emulsion obtained by dispersing an oil phase in water phase, an emulsion obtained by dispersing water phase in water phase, a suspension, a solid, a gel, Pastes, foams, or aerosol compositions. Compositions of such formulations may be prepared according to conventional methods in the art.

또한, 본 발명에 따른 조성물은 상기한 물질 이외에 주 효과를 손상시키지 않는 범위 내에서, 바람직하게는 주 효과에 상승 효과를 줄 수 있는 다른 성분들을 포함할 수 있다. 또한 본 발명에 따른 조성물은 보습제, 에몰리언트제, 자외선 흡수제, 방부제, 살균제, 산화 방지제, pH 조정제, 유기 및 무기 안료, 향료, 냉감제 또는 제한제를 더 포함할 수 있다. 상기 성분의 배합량은 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 당업자가 용이하게 선정 가능하며, 그 배합량은 조성물 총 중량에 대하여 0.01~5중량%, 구체적으로 0.01~3중량%일 수 있다.In addition, the composition according to the present invention may contain, in addition to the above-mentioned substances, other ingredients which can give a synergistic effect to the main effect, to the extent that the main effect is not impaired. The composition according to the present invention may further comprise a humectant, an emollient, an ultraviolet absorber, an antiseptic, a bactericide, an antioxidant, a pH adjuster, an organic or inorganic pigment, a perfume, a cold agent or a limiting agent. The compounding amount of the above components can be easily selected by a person skilled in the art within the range not impairing the object and effect of the present invention, and the amount thereof may be from 0.01 to 5% by weight, specifically from 0.01 to 3% by weight based on the total weight of the composition .

또한, 본 발명의 조성물은 본 발명의 조성물은 선택적으로 기타 부형제를 사용하고 적절하게 배합하여 건조분말, 과립제, 캡슐제, 정제, 환제, 음료, 유상액 형태, 다이어트바, 쵸콜렛, 캬라멜 제형, 시리얼 또는 과자류 등으로 제형화하여 건강기능 식품 및 일반식품 등으로 사용할 수 있다.
In addition, the composition of the present invention may be prepared by using the composition of the present invention optionally in combination with other excipients, and may be appropriately formulated into a dry powder, granules, capsules, tablets, pills, beverages, emulsion liquids, diet bars, Or confectionary, and can be used as health functional foods and general foods.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for illustrating the present invention and that the scope of the present invention is not construed as being limited by these embodiments.

[제조예 1] 감초 발효 추출물의 제조 [Preparation Example 1] Preparation of licorice fermented extract

건조된 감초 1kg을 믹서기로 분쇄한 뒤 물 5L를 넣고 교반 추출한 다음 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액에 PEXTINEX 0.1%를 추가한 후 40℃에서 3일간 교반 하였다. 이후 원심분리를 하고 나서 상등액을 제거하고 침전물을 99% 에탄올로 교반 추출하였다. 이를 다시 원심분리를 하고 상등액만 분리하여 감압 농축하여, 감초 발효 추출물을 125g을 수득하였다.
1 kg of dried licorice was pulverized with a blender, 5 L of water was added, stirred and extracted, and then immersed at 15 캜 for 1 day. Thereafter, the residue and the filtrate were separated by filtration and centrifugation through filter cloth, PEXTINEX 0.1% was added to the separated filtrate, and the mixture was stirred at 40 ° C for 3 days. After centrifugation, the supernatant was removed and the precipitate was extracted with 99% ethanol. This was centrifuged again, and only the supernatant was separated and concentrated under reduced pressure to obtain 125 g of licorice fermented extract.

[제조예 2] 진피 발효 추출물의 제조[Preparation Example 2] Preparation of dermal fermentation extract

완전 건조된 진귤 과피 500g을 10 메쉬(mesh)로 분쇄하여 증류수 950g을 가하고 알파-아밀라아제(α-amylase) 15g을 처리하였다. 온도를 70℃ 고정한 교반 배양기에서 20시간 동안 진탕 배양기(LSB.045S, KOR)를 이용하여 발효하였다. 발효액을 -80℃ 초저온냉동고(ilshinbiobase 905, KOR)에서 24시간 동결한 뒤 동결건조기(ilshinbiobase PVTFD20R, KOR)를 이용하여 48시간 동결건조 하여 발효 파우더를 제조하였다. 본 발효 파우더를 70% 에탄올을 부피 비로 20배 가한 후 상온에서 20시간 동안 교반 하면서 추출하였다. 현대 마이크로 NO.100(3um) 필터 페이퍼를 이용하여 여과하고 감압 농축기를 이용하여 여액 중의 용매를 증류 제거하고 동결건조하여, 진피 발효 추출물을 63g을 수득하였다.
500 g of completely dried Tangerine peel was crushed to 10 mesh and 950 g of distilled water was added and 15 g of? -Amylase was treated. The mixture was fermented in a shaking incubator (LSB.045S, KOR) for 20 hours in a stirred incubator at a temperature of 70 ° C. The fermentation broth was frozen at -80 ° C for 24 hours in a cryogenic freezer (ilshinbiobase 905, KOR) and lyophilized for 48 hours using a freeze dryer (ilshinbiobase PVTFD20R, KOR) to produce a fermented powder. The fermented powder was extracted with 20% by volume of 70% ethanol while stirring at room temperature for 20 hours. Filtration was performed using Hyundai Micro NO. 100 (3um) filter paper, the solvent in the filtrate was distilled off using a vacuum concentrator, and lyophilized to obtain 63 g of a dermis fermentation extract.

[실험예 1] 3T3-L1 지방 세포에서 지방 분화 억제 효과 평가[Experimental Example 1] Evaluation of lipid differentiation inhibitory effect in 3T3-L1 adipocytes

실험에 사용한 마우스 전구지방 세포 3T3-L1 (CL-173)는 ATCC (American Type Culture Collection, Manassas, VA, USA)로부터 구입하였고, 상기 세포를 10% 소태아혈청(fetal bovine calf serum, FCS)을 첨가한 DMEM(Dulbecco's modified Eagle's medium) 배지에 접종하여, 37℃, 10% CO2의 조건에서 배양하였다. 3T3-L1 전구지방 세포를 12 또는 24 웰플레이트에 분주한 후 100% 컨플루언시(confluency) 시점이 되면, MDI(0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 1 μM 덱사메타손, 1 μg/mL 인슐린)를 포함하는 10% FBS DMEM 배지로 지방 세포 분화를 2일 동안 유도하였고, 이후, 1 μg/mL 인슐린이 함유된 10% FBS DMEM으로 2일 동안 배양하였다. 이후 10% FBS DMEM 배양액으로 교체하고 2일 동안 배양하였다. 지방 세포 분화 유도 동안 실험물질인 실시예 1 및 비교예 1~4를 각 배양액에 처리하였다. 음성 대조군으로는 DMSO를 사용하였고, 양성 대조군으로는 지방분화를 억제하는 표준 물질로 알려진 레티노산(retinoic acid) 1μg/mL 및 3μg/mL을 사용하였다. 분화가 완성되는 시점에 지방 세포 분화 정도를 Oil-Red O 염색을 통해 관찰하였다. 즉, 분화 후에 배지를 제거한 뒤 PBS로 세척하고, 10% 포름알데하이드 용액으로 세포를 상온에서 30분 고정하였다. 이후 용액을 제거하고 PBS로 2번 세척하고 70% 알코올로 2번 세척한 후 Oil Red O 용액을 이용하여 염색하였다. 염색된 세포는 현미경 관찰 후 이소프로필 알코올을 이용하여 용해 한 후 490nm에서 흡광도를 측정하였다.The mouse preadipocyte 3T3-L1 (CL-173) used in the experiment was purchased from ATCC (American Type Culture Collection, Manassas, Va., USA) and the cells were inoculated into 10% fetal bovine calf serum It was inoculated on adding a DMEM (Dulbecco's modified Eagle's medium ) culture medium, and cultured at 37 ℃, the conditions of 10% CO 2. 3T3-L1 progenitor adipocytes were plated on 12 or 24 well plates and plated at 100% confluency with MDI (0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 1 μM dexamethasone, 1 μg / mL insulin) for 2 days, and then cultured for 2 days with 10% FBS DMEM containing 1 μg / mL insulin. The cells were then replaced with 10% FBS DMEM and cultured for 2 days. During the induction of adipocyte differentiation, the experimental material, Example 1 and Comparative Examples 1 to 4, were treated with each culture. DMSO was used as a negative control, and 1 μg / mL and 3 μg / mL of retinoic acid, which are known standard substances for inhibiting lipid differentiation, were used as a positive control. At the completion of differentiation, the degree of adipocyte differentiation was observed through Oil-Red O staining. That is, after differentiation, the medium was removed, washed with PBS, and the cells were fixed with 10% formaldehyde solution for 30 minutes at room temperature. Then, the solution was removed, washed twice with PBS, washed twice with 70% alcohol, and stained with Oil Red O solution. After staining the cells with a microscope and dissolving them in isopropyl alcohol, absorbance was measured at 490 nm.

시료정보Sample information 저해능 (%)Low performance (%) 음성 대조군Negative control group DMSODMSO 12.412.4 양성 대조군 1Positive control 1 레티노산 1 μg/mlRetinoic acid 1 μg / ml 25.825.8 양성 대조군 2Positive control 2 레티노산 3 μg/mlRetinoic acid 3 μg / ml 33.033.0 비교예 1Comparative Example 1 감초 발효 추출물 10 μg/mLLicorice fermented extract 10 μg / mL 17.217.2 비교예 2Comparative Example 2 진피 발효 추출물 10 μg/mLDermis fermented extract 10 μg / mL 29.429.4 비교예 3Comparative Example 3 감초 발효 추출물 20 μg/mLLicorice fermented extract 20 μg / mL 25.825.8 비교예 4Comparative Example 4 진피 발효 추출물 20 μg/mLDermal fermentation extract 20 μg / mL 31.131.1 실시예 1Example 1 감초 발효 추출물+진피 발효 추출물 10 μg/mLLicorice fermentation extract + dermis fermentation extract 10 μg / mL 46.646.6

상기 표 1을 살펴보면, 비교예 1인 감초 발효 추출물과 비교예 2인 진피 발효 추출물은 지방 세포 분화를 억제 시켰다는 것을 확인할 수 있었다. 특히 실시예 1인 감초 발효 추출물과 진피 발효 추출물을 1:1 비율로 혼합하여 처리한 경우, 비교예 1~2에 비하여 우수한 효과를 가짐을 알 수 있었다. 또한 비교예 3인 2배 농도의 감초 발효 추출물, 진피 발효 추출물 처리시에 비하여 실시예 1의 경우 더 우수한 지방 세포 분화 억제 효과를 나타내어 감초 발효 추출물과 진피 발효 추출물을 혼합할 경우 시너지 효과가 나타남을 확인할 수 있었다.
As shown in Table 1, it was confirmed that the licorice fermented extract of Comparative Example 1 and the dandruff fermentation extract of Comparative Example 2 inhibited adipocyte differentiation. In particular, it was found that when the licorice fermented extract of Example 1 and the dandruff fermentation extract were mixed at a ratio of 1: 1, they had an excellent effect as compared with Comparative Examples 1 and 2. In addition, in Example 1, the liposome fermentation extract and the dermis fermentation extract showed more excellent inhibitory effect on the differentiation of the adipocyte compared to the case of the 2-fold concentration of Comparative Example 3, which is synergistic effect when mixed with the licorice fermentation extract and the dermis fermentation extract I could confirm.

[실험예 2] 3T3-L1 지방 세포에서 지방 분해 효과 평가[Experimental Example 2] Evaluation of lipolysis effect in 3T3-L1 adipocytes

12 또는 24 웰플레이트에서 완전히 분화된 3T3-L1 지방 세포를 2% BSA(fatty acid-free bovine serum albumin)가 포함된 DMEM에서 실험물질인 실시예 1 및 비교예 1~4를 처리하여 4시간 동안 배양한다. 중성지방 분해로 유리되어 나온 글리세롤의 양은 세포 상층액(배양 배지)과 유리 글리세롤 시약(free glycerol reagent; Sigma, USA)을 15분간 반응시켜 정량하였다. 음성 대조군으로는 DMSO를 사용하였고, 양성 대조군으로는 이소프로테레놀(isoproterenol)과 카페인 10μg/mL을 사용하였다. 글리세롤 정량을 위해 표준품인 표준 글리세롤(standard glycerol; Sigma) 25μg/10μL를 위와 동일한 방법으로 반응시켜 540nm에서 흡광도를 측정하였다. 글리세롤의 함량은 아래의 계산식으로 산출하였다.
3T3-L1 adipocytes completely differentiated in 12- or 24-well plates were treated with DMEM containing 2% BSA (fatty acid-free bovine serum albumin) in Example 1 and Comparative Examples 1 to 4 for 4 hours Lt; / RTI > The amount of glycerol liberated by neutral lipid degradation was determined by reacting the cell supernatant (culture medium) with free glycerol reagent (Sigma, USA) for 15 minutes. DMSO was used as a negative control, and isoproterenol and caffeine 10 μg / mL were used as a positive control. For the determination of glycerol, 25 μg / 10 μL of a standard glycerol (standard glycerol; Sigma) was reacted in the same manner as above to measure the absorbance at 540 nm. The content of glycerol was calculated by the following formula.

시료정보Sample information 글리세롤 O.DGlycerol O.D 대조군Control group DMSODMSO 0.0920.092 비교예 1Comparative Example 1 감초 발효 추출물 10 μg/mLLicorice fermented extract 10 μg / mL 0.1190.119 비교예 2Comparative Example 2 진피 발효 추출물 10 μg/mLDermis fermented extract 10 μg / mL 0.1300.130 비교예 3Comparative Example 3 감초 발효 추출물 20 μg/mLLicorice fermented extract 20 μg / mL 0.1780.178 비교예 4Comparative Example 4 진피 발효 추출물 20 μg/mLDermal fermentation extract 20 μg / mL 0.1950.195 실시예 1Example 1 감초 발효 추출물+진피 발효 추출물 10 μg/mLLicorice fermentation extract + dermis fermentation extract 10 μg / mL 0.2490.249

상기 표 2를 살펴보면, 비교예 1인 감초 발효 추출물과 비교예 2인 진피 발효 추출물은 지방 분해 효과를 나타냄을 확인할 수 있었다. 특히, 실시예 1인 감초 발효 추출물과 진피 발효 추출물을 1:1 비율로 혼합하여 처리한 경우, 비교예 1~2에 비하여 우수한 효과를 가짐을 알 수 있었다. 또한 비교예 3인 2배 농도의 감초 발효 추출물, 진피 발효 추출물 처리시에 비하여 실시예 1의 경우 더 우수한 지방 분해 효과를 나타내어 감초 발효 추출물과 진피 발효 추출물을 혼합할 경우 시너지 효과가 나타남을 확인할 수 있었다. As shown in Table 2, the fermented licorice extract of Comparative Example 1 and the fermented dandelion extract of Comparative Example 2 showed lipolytic effect. In particular, it was found that when the licorice fermentation extract of Example 1 and the dandruff fermentation extract were mixed and treated at a ratio of 1: 1, they had an excellent effect as compared with Comparative Examples 1 and 2. In addition, Example 1 exhibited a better lipolytic effect than the case of the licorice fermentation extract and dermis fermentation extract of Comparative Example 3, which was twice the concentration of licorice, showing synergistic effects when the licorice fermentation extract and the dermis fermentation extract were mixed there was.

이상의 결과로부터, 본 발명에 의한 감초 및 진피의 발효물로부터 추출한 추출물 함유하는 조성물은 지방 세포 내 지방 분해 효과 및 지방 분화 억제 효과가 현저하게 우수하므로, 복부 슬리밍 효능에 유용한 원료임을 확인할 수 있었다.From the above results, it was confirmed that the composition containing the extract extracted from the fermented product of licorice and dermis according to the present invention is a useful raw material for abdominal slimming efficacy because it has remarkably excellent fat decomposition effect and lipid differentiation inhibiting effect in fat cells.

Claims (6)

감초 발효 추출물 및 진피 발효 추출물을 유효성분으로 함유하는 복부 비만 감소용 피부 외용제 조성물.A composition for external application for skin for reducing abdominal obesity comprising an extract of fermented licorice and a fermented extract of dermis as an active ingredient. 제1항에 있어서, 상기 감초 발효 추출물 및 진피 발효 추출물은 각각 조성물 총 중량에 대하여 0.000001~30.0중량%의 양으로 함유되는 복부 비만 감소용 피부 외용제 조성물.[Claim 3] The composition for external application for skin of abdominal obesity according to claim 1, wherein the licorice fermentation extract and the dermis fermentation extract are contained in an amount of 0.000001 to 30.0 wt% based on the total weight of the composition. 제1항에 있어서, 상기 감초 발효 추출물 및 진피 발효 추출물은 중량비로 0.01~100:1의 비율로 혼합사용되는 복부 비만 감소용 피부 외용제 조성물.The composition for external application for skin of abdominal obesity according to claim 1, wherein the licorice fermentation extract and the dermis fermentation extract are mixed in a weight ratio of 0.01 to 100: 1. 감초 발효 추출물 및 진피 발효 추출물을 유효성분으로 함유하는 복부 비만 감소용 식품 조성물.A fermented extract of licorice and a fermented extract of dermis as an active ingredient. 제4항에 있어서, 상기 감초 발효 추출물 및 진피 발효 추출물은 각각 조성물 총 중량에 대하여 0.000001~30.0중량%의 양으로 함유되는 복부 비만 감소용 식품 조성물.The food composition according to claim 4, wherein the licorice fermentation extract and the dermis fermentation extract are contained in an amount of 0.000001 to 30.0% by weight based on the total weight of the composition, respectively. 제4항에 있어서, 상기 감초 발효 추출물 및 진피 발효 추출물은 중량비로 0.01~100:1의 비율로 혼합사용되는 복부 비만 감소용 식품 조성물.The food composition according to claim 4, wherein the licorice fermentation extract and the dermis fermentation extract are mixed in a weight ratio of 0.01 to 100: 1.
KR1020130146830A 2013-11-29 2013-11-29 Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity KR102120220B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130146830A KR102120220B1 (en) 2013-11-29 2013-11-29 Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130146830A KR102120220B1 (en) 2013-11-29 2013-11-29 Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity

Publications (2)

Publication Number Publication Date
KR20150063183A true KR20150063183A (en) 2015-06-09
KR102120220B1 KR102120220B1 (en) 2020-06-09

Family

ID=53503771

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130146830A KR102120220B1 (en) 2013-11-29 2013-11-29 Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity

Country Status (1)

Country Link
KR (1) KR102120220B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190053108A (en) 2017-11-09 2019-05-17 유의순 A composition comprising the complex extract for antiobesity of men
KR20190053107A (en) 2017-11-09 2019-05-17 유의순 A composition comprising the complex extract for antiobesity of women
KR20220092199A (en) * 2020-12-24 2022-07-01 제너럴바이오(주) Composition comprising fermented Glycyrrhiza uralensis extract for inhibitory effects on melanogenesis of B16F10 cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120081289A (en) * 2011-01-11 2012-07-19 한불화장품주식회사 A skin-care agent containing fermented licorice extracts
KR20130019826A (en) * 2011-08-18 2013-02-27 재단법인 대구테크노파크 The manufacturing method of fermented citrus peel extract with anti-obesity nature and the product
KR20130099572A (en) 2012-02-29 2013-09-06 주식회사비에이치텍 A composition for prevention treatment and controlling of overweight and obesity containing concentrate of fermented onion

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120081289A (en) * 2011-01-11 2012-07-19 한불화장품주식회사 A skin-care agent containing fermented licorice extracts
KR20130019826A (en) * 2011-08-18 2013-02-27 재단법인 대구테크노파크 The manufacturing method of fermented citrus peel extract with anti-obesity nature and the product
KR20130099572A (en) 2012-02-29 2013-09-06 주식회사비에이치텍 A composition for prevention treatment and controlling of overweight and obesity containing concentrate of fermented onion

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190053108A (en) 2017-11-09 2019-05-17 유의순 A composition comprising the complex extract for antiobesity of men
KR20190053107A (en) 2017-11-09 2019-05-17 유의순 A composition comprising the complex extract for antiobesity of women
KR20220092199A (en) * 2020-12-24 2022-07-01 제너럴바이오(주) Composition comprising fermented Glycyrrhiza uralensis extract for inhibitory effects on melanogenesis of B16F10 cells

Also Published As

Publication number Publication date
KR102120220B1 (en) 2020-06-09

Similar Documents

Publication Publication Date Title
KR101570847B1 (en) Cosmetic composition including an extract of the tissue-cultured dendrobium candidum multi-shoots
KR101310980B1 (en) The cosmetics and functional food composition for improving anti-oxidant, anti-inflammatory and anti-wrinkling containing lycium chinense mill stem extracts
KR101892097B1 (en) Cosmetic composition for reducing acne containing extract of senna tora
JP5512067B2 (en) Skin cosmetics
KR102120220B1 (en) Cosmetic or food composition comprising natural plants fermented extracts for reducing abdominal obesity
KR101742029B1 (en) Composition for preventing skin anti-aging and skin anti-wrinkle comprising a resveratrol-germinated brown rice
JP5219344B2 (en) Topical skin preparation
KR20190064714A (en) Anti-inflammatory agent containing backhousia citriodora extract
JP4460420B2 (en) Collagen production promoter
KR20090103823A (en) Anti-aging agent external preparation for skin, and food and drink
JP6846106B2 (en) DKK1 expression promoter and whitening agent
EP3162375B1 (en) Whitening composition comprising scutellaria alpina extract
KR101702621B1 (en) Anti-inflammatory agent containing phlox subulata extract
KR20130123490A (en) Cosmetic composition comprising maackia amurensis extract for skin whitening
JP2011032177A (en) Inhibitor of kit cleavage
KR102057376B1 (en) Composition for skin whitening comprising extract of stichopus japonicas red
KR101310655B1 (en) Cosmetic composition which contains trapa japonica flerov. extraction as active compotnets and the preparation method thereof
CN114949039B (en) Plant ferment and use thereof for producing lipid-reducing compositions
JP6017259B2 (en) Endothelin action inhibitor
KR20180120120A (en) Composition for skin anti-aging or moisturization comprising extract of marian plum
KR102182710B1 (en) Compositions for Skin Moisture Comprising Extract of Plectranthus tomentosa or Complex Extract thereof
KR20110022013A (en) Cosmetic composition for skin whitening comprising extract of hedera rhombea
KR101185903B1 (en) Anti-inflammatory agent containing eupatorium japonicum extract
KR102335029B1 (en) Cosmetic composition comprising the extract from solid fermented Terminalia chebula Retz with Phellinus baumii
JP6378969B2 (en) Whitening composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant